Cited 0 time in
CONDITIONAL RELATIVE SURVIVAL OF CERVICAL CANCER: A KOREAN CENTRAL CANCER REGISTRY STUDY
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Bae, J. | - |
| dc.date.accessioned | 2021-09-27T06:17:29Z | - |
| dc.date.available | 2021-09-27T06:17:29Z | - |
| dc.date.created | 2021-09-23 | - |
| dc.date.issued | 2019-11 | - |
| dc.identifier.issn | 1048-891X | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/133082 | - |
| dc.description.abstract | Introduction/Background Conditional relative survival (CRS) can complement the conventional 5-year relative survival that does not take into account the time the patient has survived after diagnosis. The purpose of this study was to evaluate the 5-year CRS and associated risk factors among Korean cervical cancer patients. Methodology We identified 78,606 cervical cancer cases with a diagnosis between 1996 and 2015 in the Korea Central Cancer Registry. The CRS rates were calculated according to age, history, treatment method and stage at diagnosis. Results The relative survival rate for five years was 80.6%, and for five years the CRS increased for the first two years and remained stable at 94.3% after five years of survival. Patients under the age of 40 had the highest level (88.9 percent) in five years, while those aged 70 or older had the worst CRS (55.0 percent) in five years. The localized disease had 91.9% CRS, local transferency had 72.3% CRS, and remote transitions were 27.0%. Conclusion Patients with cervical cancer showed an increase in CRS rates, which varied with age, histology, and stage at diagnosis. The CRS analysis therefore provides a more detailed perspective on survival over the years after the initial diagnosis or treatment. | - |
| dc.language | 영어 | - |
| dc.language.iso | en | - |
| dc.publisher | BMJ PUBLISHING GROUP | - |
| dc.title | CONDITIONAL RELATIVE SURVIVAL OF CERVICAL CANCER: A KOREAN CENTRAL CANCER REGISTRY STUDY | - |
| dc.type | Conference | - |
| dc.contributor.affiliatedAuthor | Bae, J. | - |
| dc.identifier.wosid | 000523502501060 | - |
| dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, pp.A199 | - |
| dc.relation.isPartOf | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | - |
| dc.relation.isPartOf | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | - |
| dc.citation.title | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | - |
| dc.citation.startPage | A199 | - |
| dc.citation.endPage | A199 | - |
| dc.citation.conferencePlace | UK | - |
| dc.citation.conferenceDate | 2019-11 | - |
| dc.type.rims | CONF | - |
| dc.description.journalClass | 1 | - |
| dc.identifier.url | https://ijgc.bmj.com/content/29/Suppl_4/A199.1 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
